Poonam S. Gulati - La Canada CA, US Sarnath Chattaraj - Simi Valley CA, US Elango S. Minnoor - Northridge CA, US Eugene Levin - West Hills CA, US Xiao Zhu - Valencia CA, US William P. Van Antwerp - Valencia CA, US
Assignee:
Medtronic MiniMed, Inc. - Northridge CA
International Classification:
C12Q 1/26
US Classification:
435 25
Abstract:
Embodiments of the invention include polypeptide formulations and methods for making, using and characterizing them. Embodiment of the invention include stabilized polypeptide formulations, for example stable glucose oxidase formulations that can be used with glucose sensors used in the management of diabetes. Another embodiment of the invention includes methods to characterize the concentration of nonionic surfactants in stabilized polypeptide formulation for example stable insulin formulations that can be used in the treatment of diabetes.
Polypeptide Formulations And Methods For Making, Using And Characterizing Them
Poonam S. Gulati - La Canada CA, US Sarnath Chattaraj - Simi Valley CA, US Elango S. Minnoor - Northridge CA, US Eugene Levin - West Hills CA, US Xiao Zhu - Valencia CA, US William P. Van Antwerp - Valencia CA, US
International Classification:
G01N 33/44 G01N 30/02
US Classification:
436 85, 436161
Abstract:
Embodiments of the invention include polypeptide formulations and methods for making, using and characterizing them. Embodiment of the invention include stabilized polypeptide formulations, for example stable glucose oxidase formulations that can be used with glucose sensors used in the management of diabetes. Another embodiment of the invention includes methods to characterize the concentration of nonionic surfactants in stabilized polypeptide formulation for example stable insulin formulations that can be used in the treatment of diabetes.